novo nordisk ozempic news

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

the chief executive of Ozempic maker Novo Nordisk warned Wednesday. “Honestly, I’m quite alarmed by what we see in the US now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN. “Patients who believe that they’re getting access ...

San Francisco Examiner · 3d

Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide

THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned ... I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen ...

Becker's Hospital Review · 2d

Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October requested the FDA block compounding pharmacies from producing versions of the drug, saying semaglutide is too complex for others to replicate safely.

6don MSN

Scientist behind Novo Nordisk's Ozempic, Wegovy started her career developing laundry detergent

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

10h

New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

6don MSN

Ozempic, Wegovy sales inject wealth into Novo Nordisk home country of Denmark

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

Barron's on MSN3d

Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs

Novo Nordisk posted solid quarterly results Wednesday before the market open.The drug maker’s sales came in at 71.3 billion ...

STAT10d

Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

FiercePharma3d

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Investopedia on MSN3d

Novo Nordisk Stock Slips as Sales Grow Less Than Expected

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

NBC New York10d

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

All doses of Novo Nordisk's weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the FDA's drug shortage database. It is a sign that ...

Yahoo17h

A stronger Ozempic, a Boeing supplier in trouble, and a simpler Starbucks: Business news roundup

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results